IPCA Laboratories Balance Sheet Annual

Trade

BSE: 524494 | NSE: IPCALAB | ISIN: INE571A01038 | Sector: Biotechnology & Drugs

1,341.50 -11.00 (-0.81%)Updated : 19 Apr 2024

Interim Data

Annual Data

Fiscal Period	2023	2022	2021	2020
Period End Date	Mar 23	Mar 22	Mar 21	Mar 20
Cash	91.68	72.19	105.97	54.73
Cash Equivalents	1,166.17	203.00	60.00	3.73
Short Term Investments	929.54	1,094.86	602.84	359.77
Cashand Short Term Investments	2,187.39	1,370.05	768.81	418.23
Accounts Receivable- Trade Net	1,026.33	926.62	815.69	899.26
Total Receivables Net	1,189.87	1,154.65	1,032.48	1,078.27
Total Inventory	1,773.21	1,889.73	1,610.55	1,338.42
Prepaid Expenses	31.19	18.86	18.74	14.62
Other Current Assets Total	7.61	23.88	6.38	6.17
Total Current Assets	5,189.27	4,457.17	3,436.96	2,855.71
Property/ Plant/ Equipment Total- Gross	4,125.20	3,691.66	3,140.24	2,811.79
Accumulated Depreciation Total	-1,430.62	-1,189.07	-993.79	-818.54
Property/ Plant/ Equipment Total- Net	2,694.58	2,502.59	2,146.45	1,993.25
Goodwill Net	38.14	38.84	46.60	62.44
Intangibles Net	159.09	167.19	114.20	136.32
Long Term Investments	302.66	269.88	111.43	71.31
Note Receivable- Long Term	216.39	173.08	188.69	130.71
Other Long Term Assets Total	26.30	14.78	24.03	10.09
Total Assets	8,626.43	7,623.53	6,068.36	5,259.83
Accounts Payable	525.06	557.70	664.86	609.85
Accrued Expenses	37.89	52.69	30.02	28.53
Notes Payable/ Short Term Debt	661.82	367.81	176.61	310.95
Current Portof LT Debt/ Capital Leases	150.59	32.73	71.40	73.78
Other Currentliabilities Total	430.46	454.95	217.65	303.31
Total Current Liabilities	1,805.82	1,465.88	1,160.54	1,326.42
Long Term Debt	651.78	395.18	9.13	102.97
Capital Lease Obligations	17.08	11.50	8.25	13.02
Total Long Term Debt	668.86	406.68	17.38	115.99
Total Debt	1,481.27	807.22	265.39	500.72
Deferred Income Tax	189.16	164.38	133.55	141.82
Minority Interest	73.30	76.92	14.53	13.63
Other Liabilities Total	47.27	44.83	40.71	34.49
Total Liabilities	2,784.41	2,158.69	1,366.71	1,632.35
Common Stock Total	25.37	25.37	25.37	25.27
Additional Paid- In Capital	96.52	96.52	96.52	48.87
Retained Earnings( Accumulated Deficit)	5,721.91	5,353.96	4,565.65	3,538.22
Other Equity Total	-1.78	-11.01	14.11	15.12
Total Equity	5,842.02	5,464.84	4,701.65	3,627.48
Total Liabilities Shareholders' Equity	8,626.43	7,623.53	6,068.36	5,259.83
Total Common Shares Outstanding	25.37	25.37	25.37	25.27
Tangible Book Valueper Share Common Eq	222.49	207.28	178.98	135.68